These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27268946)

  • 1. Prediction of salt effects on protein phase behavior by HIC retention and thermal stability.
    Baumgartner K; Großhans S; Schütz J; Suhm S; Hubbuch J
    J Pharm Biomed Anal; 2016 Sep; 128():216-225. PubMed ID: 27268946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of protein phase diagrams by microbatch experiments: exploring the influence of precipitants and pH.
    Baumgartner K; Galm L; Nötzold J; Sigloch H; Morgenstern J; Schleining K; Suhm S; Oelmeier SA; Hubbuch J
    Int J Pharm; 2015 Feb; 479(1):28-40. PubMed ID: 25541147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of salt properties with electro-acoustic measurements and their effect on dynamic binding capacity in hydrophobic interaction chromatography.
    Müller E; Faude A
    J Chromatogr A; 2008 Jan; 1177(2):215-25. PubMed ID: 18037423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization, solubility and thermodynamics of the highly thermostable glucose isomerase from Streptomyces sp. strain.
    Borgi MA; Rhimi M; Kadri A
    Gen Physiol Biophys; 2014; 33(2):227-34. PubMed ID: 24177020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput protein precipitation and hydrophobic interaction chromatography: salt effects and thermodynamic interrelation.
    Nfor BK; Hylkema NN; Wiedhaup KR; Verhaert PD; van der Wielen LA; Ottens M
    J Chromatogr A; 2011 Dec; 1218(49):8958-73. PubMed ID: 21868020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of mixed salts on retention behavior of model proteins in cation exchange chromatography.
    Fuchs T; Pälchen A; Jupke A
    J Chromatogr A; 2023 May; 1696():463968. PubMed ID: 37054639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive study to protein retention in hydrophobic interaction chromatography.
    Baca M; De Vos J; Bruylants G; Bartik K; Liu X; Cook K; Eeltink S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():182-188. PubMed ID: 27237734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditions.
    Ghose S; Tao Y; Conley L; Cecchini D
    MAbs; 2013; 5(5):795-800. PubMed ID: 23884181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility and binding properties of PEGylated lysozyme derivatives with increasing molecular weight on hydrophobic-interaction chromatographic resins.
    Müller E; Josic D; Schröder T; Moosmann A
    J Chromatogr A; 2010 Jul; 1217(28):4696-703. PubMed ID: 20570270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalizing a two-conformation model for describing salt and temperature effects on protein retention and stability in hydrophobic interaction chromatography.
    Xiao Y; Rathore A; O'Connell JP; Fernandez EJ
    J Chromatogr A; 2007 Jul; 1157(1-2):197-206. PubMed ID: 17524412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic second virial cross-coefficient measurements for binary combination of lysozyme, ovalbumin, and α-amylase in salt solutions.
    Mehta CM; White ET; Litster JD
    Biotechnol Prog; 2013; 29(5):1203-11. PubMed ID: 23804362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody.
    Menzen T; Friess W
    J Pharm Sci; 2014 Feb; 103(2):445-55. PubMed ID: 24382634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic interaction chromatography of proteins. III. Unfolding of proteins upon adsorption.
    Jungbauer A; Machold C; Hahn R
    J Chromatogr A; 2005 Jun; 1079(1-2):221-8. PubMed ID: 16038308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of poly(N-isopropylacrylamide)-grafted polymer monolith for hydrophobic interaction chromatography of proteins.
    Zhang R; Yang G; Xin P; Qi L; Chen Y
    J Chromatogr A; 2009 Mar; 1216(12):2404-11. PubMed ID: 19193382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salts employed in hydrophobic interaction chromatography can change protein structure - insights from protein-ligand interaction thermodynamics, circular dichroism spectroscopy and small angle X-ray scattering.
    Komaromy AZ; Kulsing C; Boysen RI; Hearn MT
    Biotechnol J; 2015 Mar; 10(3):417-26. PubMed ID: 25690783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of mixed salts on the capacity of HIC adsorbers: A predictive correlation to the surface tension and the aggregation temperature.
    Baumgartner K; Amrhein S; Oelmeier SA; Hubbuch J
    Biotechnol Prog; 2016 Mar; 32(2):346-54. PubMed ID: 26358156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a novel dual-retention mechanism mixed-mode stationary phase with PEG 400 and succinic anhydride as ligand for protein separation in WCX and HIC modes.
    Song C; Wang J; Zhao K; Bai Q
    Biomed Chromatogr; 2013 Dec; 27(12):1741-53. PubMed ID: 23893694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating multidimensional short-term empirical protein properties to long-term protein physical stability data via empirical phase diagrams.
    Klijn ME; Hubbuch J
    Int J Pharm; 2019 Apr; 560():166-174. PubMed ID: 30769132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of a novel dual-function strong cation exchange/hydrophobic interaction chromatography stationary phase for protein separation.
    Zhao K; Yang L; Wang X; Bai Q; Yang F; Wang F
    Talanta; 2012 Aug; 98():86-94. PubMed ID: 22939132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical method development for the separation of monoclonal antibodies and antibody-drug-conjugate species in hydrophobic interaction chromatoraphy, part 2: Optimization of the phase system.
    Cusumano A; Guillarme D; Beck A; Fekete S
    J Pharm Biomed Anal; 2016 Mar; 121():161-173. PubMed ID: 26808065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.